KDR and renal cell carcinoma: Although, the prognosis for patients with this disease has recently improved due to earlier detection of RCC and expansion of treatment possibilities such as mTor inhibitors and VEGFR-targeted tyrosine kinase inhibitors [1], these treatments rarely yield complete responses.